Literature DB >> 12789298

Harmful potential of viral vectors fuels doubts over gene therapy.

Erika Check.   

Abstract

Mesh：

Year:  2003        PMID： 12789298     DOI： 10.1038/423573a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  20 years of gene therapy for SCID.

Authors:  Alain Fischer; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo
Journal:  Nat Immunol       Date:  2010-06       Impact factor: 25.606

Review 2.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

3.  Delivery of chemotropic proteins and improvement of dopaminergic neuron outgrowth through a thixotropic hybrid nano-gel.

Authors:  Elisa Tamariz; Andrew C A Wan; Y Shona Pek; Magda Giordano; Genoveva Hernández-Padrón; Alfredo Varela-Echavarría; Iván Velasco; Víctor M Castaño
Journal:  J Mater Sci Mater Med       Date:  2011-07-09       Impact factor: 3.896

4.  Nanoparticle delivery of RNA-based therapeutics to alter the vocal fold tissue response to injury.

Authors:  Nao Hiwatashi; Iv Kraja; Peter A Benedict; Gregory R Dion; Renjie Bing; Bernard Rousseau; Milan R Amin; Danielle M Nalband; Kent Kirshenbaum; Ryan C Branski
Journal:  Laryngoscope       Date:  2017-12-14       Impact factor: 3.325

Review 5.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

6.  Preliminary study of a novel transfection modality for in vivo siRNA delivery to vocal fold fibroblasts.

Authors:  Iv Kraja; Renjie Bing; Nao Hiwatashi; Bernard Rousseau; Danielle Nalband; Kent Kirshenbaum; Ryan C Branski
Journal:  Laryngoscope       Date:  2016-12-20       Impact factor: 3.325

7.  Varying the unsaturation in N4,N9-dioctadecanoyl spermines: nonviral lipopolyamine vectors for more efficient plasmid DNA formulation.

Authors:  Osama A A Ahmed; Charareh Pourzand; Ian S Blagbrough
Journal:  Pharm Res       Date:  2006-12-31       Impact factor: 4.200

8.  Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.

Authors:  María Moreno-Igoa; Ana Cristina Calvo; Clara Penas; Raquel Manzano; Sara Oliván; María Jesús Muñoz; Renzo Mancuso; Pilar Zaragoza; José Aguilera; Xavier Navarro; Rosario Osta Pinzolas
Journal:  J Mol Med (Berl)       Date:  2010-03       Impact factor: 4.599

9.  Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.

Authors:  Francesco Del Galdo; Federica Sotgia; Cecilia J de Almeida; Jean-Francois Jasmin; Megan Musick; Michael P Lisanti; Sergio A Jiménez
Journal:  Arthritis Rheum       Date:  2008-09

10.  Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion.

Authors:  Bahareh Sayyar; Megan Dodd; Jianping Wen; Shirley Ma; Leah Marquez-Curtis; Anna Janowska-Wieczorek; Gonzalo Hortelano
Journal:  J Tissue Eng       Date:  2012-11-02       Impact factor: 7.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.